Undetermined stroke with an embolic pattern—a common phenotype with high early recurrence risk
- 4 July 2015
- journal article
- research article
- Published by Taylor & Francis Ltd in Annals of Medicine
- Vol. 47 (5), 406-413
- https://doi.org/10.3109/07853890.2015.1057612
Abstract
Introduction. Undetermined strokes with an embolic pattern (USEP) represent a common phenotype. We assessed their frequency and compared USEP with cardioembolic stroke with a known source and non-cardioembolic stroke etiology. Methods. Study patients were 540 consecutive ischemic stroke patients admitted to Helsinki University Hospital with primary end-point of recurrent stroke in a 21-month follow-up. Cox regression adjusting for CHA2DS2-VASc and anticoagulation estimated the risk of USEP on recurrent stroke. Results. A total of 229 (42.4%) patients had a non-cardioembolic stroke etiology, 184 (34.1%) had a cardioembolic stroke with a known source, and 127 (23.5%) were classified as USEP. USEP patients had less diabetes and prior TIA, with more severe symptoms than the non-cardioembolic stroke cases. They were younger, had fewer comorbidities, and less severe symptoms than the cardioembolic stroke patients. Cumulative risk of recurrent stroke was 10.0% (95% CI 4.1%–15.9%) for USEP, 5.0% (1.1%–8.9%) for cardioembolic strokes, and 5.0% (3.0%–7.0%) for non- cardioembolic strokes (P = 0.089). USEP associated with a higher risk of recurrent stroke compared to non-cardioembolic strokes (hazard ratio 2.36, 95% CI 1.02–5.47; P = 0.046) and cardioembolic stroke with a known source (1.83, 1.07–3.14; P = 0.028). Conclusions. Despite their younger age and more favorable risk factor profile compared with other phenotypes, USEP exhibited a high risk of stroke recurrence.This publication has 27 references indexed in Scilit:
- Embolic strokes of undetermined source: the case for a new clinical constructThe Lancet Neurology, 2014
- Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen OvaleThe New England Journal of Medicine, 2012
- Long-Term Risk of Recurrent Stroke in Young Cryptogenic Stroke Patients with and without Patent Foramen OvaleInternational Journal of Stroke, 2011
- Recurrent ischemic events in young adults after first‐ever ischemic strokeAnnals of Neurology, 2010
- Recurrent cerebral ischemia in medically treated patent foramen ovaleNeurology, 2009
- Comparison of Warfarin versus Aspirin for the Prevention of Recurrent Stroke or Death: Subgroup Analyses from the Warfarin-Aspirin Recurrent Stroke StudyCerebrovascular Diseases, 2006
- Stroke recurrence within the first year following cerebral infarction - Tottori University Lacunar Infarction Prognosis Study (TULIPS)*Acta Neurologica Scandinavica, 2004
- Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen OvaleStroke, 2004
- Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or BothThe New England Journal of Medicine, 2001
- Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic ImplicationsStroke, 2000